Detalhe da pesquisa
1.
Size-advantage of monovalent nanobodies against the macrophage mannose receptor for deep tumor penetration and tumor-associated macrophage targeting.
Theranostics
; 13(1): 355-373, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36593955
2.
Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment.
Front Immunol
; 13: 1003975, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36531986
3.
Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages.
Cancer Res
; 82(20): 3785-3801, 2022 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35979635
4.
Targeted Repolarization of Tumor-Associated Macrophages via Imidazoquinoline-Linked Nanobodies.
Adv Sci (Weinh)
; 8(10): 2004574, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34026453
5.
IL1ß Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D.
Cancer Immunol Res
; 9(3): 309-323, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33361087
6.
Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy.
Front Immunol
; 11: 1395, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32733461
7.
Unleashing Tumour-Dendritic Cells to Fight Cancer by Tackling Their Three A's: Abundance, Activation and Antigen-Delivery.
Cancers (Basel)
; 11(5)2019 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31091774